STOCKHOLDERS' EQUITY	9 Months Ended
Dec. 31, 2017
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	Common stock On July 24, 2017, pursuant to a Reorganization and Share Exchange Agreement, by and among, the Company and Quasuras Inc., the Company acquired 100% of the issued and outstanding shares of Quasuras for 7,582,000 shares of the Company, resulting in Quasuras becoming a wholly-owned subsidiary of the Company. The historical equity for Quasuras was restated pursuant to the reorganization. The Company has 50,000,000 shares of common stock authorized. The par value of the shares is $0.001. As of December 31, 2017, 15,983,000 shares of common stock of the Company were issued and outstanding. Preferred Stock The Company has 5,000,000 shares of preferred stock authorized. The par value of the shares is $0.001. As of December 31, 2017, none of the shares of preferred stock of the Company were issued. Stock Options On October 19, 2017, the board approved an Employee Stock Option Program (“ESOP”) that reserves 3,000,000 shares to be issued. As of December 31, 2017, no options has been granted.

STOCKHOLDERS' EQUITY

9 Months Ended

Dec. 31, 2017

Common stock

On July 24, 2017, pursuant to a Reorganization and Share Exchange Agreement, by and among, the Company and Quasuras Inc., the Company acquired 100% of the issued and outstanding shares of Quasuras for 7,582,000 shares of the Company, resulting in Quasuras becoming a wholly-owned subsidiary of the Company. The historical equity for Quasuras was restated pursuant to the reorganization.

The Company has 50,000,000 shares of common stock authorized. The par value of the shares is $0.001. As of December 31, 2017, 15,983,000 shares of common stock of the Company were issued and outstanding.

Preferred Stock

The Company has 5,000,000 shares of preferred stock authorized. The par value of the shares is $0.001. As of December 31, 2017, none of the shares of preferred stock of the Company were issued.

Stock Options

On October 19, 2017, the board approved an Employee Stock Option Program (“ESOP”) that reserves 3,000,000 shares to be issued. As of December 31, 2017, no options has been granted.